Group One Trading’s Ovid Therapeutics OVID Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 3120 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 3046 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 2710 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 2747 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 2918 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 2938 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 2888 |
|
|
2022
Q4 | – | Sell |
-1,532
| Closed | -$3K | – | 2883 |
|
|
2022
Q3 | $3K | Sell |
1,532
-36
| -2% | -$70 | ﹤0.01% | 1764 |
|
|
2022
Q2 | $3K | Sell |
1,568
-1,500
| -49% | -$2.87K | ﹤0.01% | 1803 |
|
|
2022
Q1 | $10K | Sell |
3,068
-9,838
| -76% | -$32.1K | ﹤0.01% | 1756 |
|
|
2021
Q4 | $41K | Sell |
12,906
-41,401
| -76% | -$132K | ﹤0.01% | 1622 |
|
|
2021
Q3 | $182K | Sell |
54,307
-11,394
| -17% | -$38.2K | ﹤0.01% | 1161 |
|
|
2021
Q2 | $257K | Sell |
65,701
-100,655
| -61% | -$394K | ﹤0.01% | 1027 |
|
|
2021
Q1 | $669K | Buy |
166,356
+100,721
| +153% | +$405K | ﹤0.01% | 671 |
|
|
2020
Q4 | $152K | Buy |
65,635
+65,573
| +105,763% | +$152K | ﹤0.01% | 922 |
|
|
2020
Q3 | $0 | Sell |
62
-8,338
| -99% | – | ﹤0.01% | 2225 |
|
|
2020
Q2 | $62K | Buy |
+8,400
| New | +$62K | ﹤0.01% | 894 |
|